Review article · 2025 · Open access

PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature

Georgia Papanikolaou, Estella S. Poloni, José A. G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin and 3 more

Clinical Pharmacology & Therapeutics, 119(4), 859–871 · Published 23 December 2025 · DOI 10.1002/cpt.70168

Open PDFView at the publisherCite this paper

In brief

“PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature” is a 2025 review article by Georgia Papanikolaou and 14 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 12 citations as of 17 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
12
Most cited in
2026 (12)
Field-weighted impact
1.10
References
85
Authors
15

Abstract

The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N-acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines. Systematic nomenclature describing NAT2 variation is essential for pharmacogenetic testing, genotype interpretation, and translation to phenotype in research and clinical settings. This GeneFocus provides an overview of NAT2 variation and describes important changes to its star allele-based nomenclature that were made as it was transitioned to PharmVar in March 2024. We also highlight and discuss challenges regarding the characterization of allelic variation and determination of allele frequencies across world populations. The "new" NAT2 PharmVar nomenclature is utilized by ClinPGx (formerly PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Papanikolaou, G., Poloni, E. S., Agúndez, J. A. G., Teixeira, R. L., Boone, E. C., Santos, A. R., Whirl‐Carrillo, M., Sangkuhl, K., Klein, T. E., Habil, M. R., Fakis, G., Minchin, R. F., Hein, D. W., Boukouvala, S., & Gaedigk, A. (2025). PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature. Clinical Pharmacology & Therapeutics, 119(4), 859–871. https://doi.org/10.1002/cpt.70168

MLA 9

Papanikolaou, Georgia, et al. “PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature.” Clinical Pharmacology & Therapeutics, vol. 119, no. 4, 2025, pp. 859–871. https://doi.org/10.1002/cpt.70168.

Chicago

Papanikolaou, Georgia, Estella S. Poloni, José A. G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, et al. 2025. “PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature.” Clinical Pharmacology & Therapeutics 119 (4): 859–871. https://doi.org/10.1002/cpt.70168.

Harvard

Papanikolaou, G. et al. (2025) ‘PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature’, Clinical Pharmacology & Therapeutics, 119(4), pp. 859–871. doi:10.1002/cpt.70168.

IEEE

G. Papanikolaou et al., “PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature,” Clinical Pharmacology & Therapeutics, vol. 119, no. 4, pp. 859–871, 2025, doi: 10.1002/cpt.70168.

BibTeX

@article{papanikolaou2025pharmvar,
  title     = {{PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature}},
  author    = {Papanikolaou, Georgia and Poloni, Estella S. and Agúndez, José A. G. and Teixeira, Raquel L.F. and Boone, Erin C. and Santos, Adalberto Rezende and Whirl‐Carrillo, Michelle and Sangkuhl, Katrin and Klein, Teri E. and Habil, Mariam R. and Fakis, Giannoulis and Minchin, Rodney F. and Hein, David W. and Boukouvala, Sotiria and Gaedigk, Andrea},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2025},
  volume    = {119},
  number    = {4},
  pages     = {859--871},
  doi       = {10.1002/cpt.70168},
  url       = {https://doi.org/10.1002/cpt.70168}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • N-acetyltransferase 2
  • NAT2
  • star alleles
  • genetic variation
  • allele frequency
  • isoniazid
  • hydralazine
  • amifampridine

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Papanikolaou, G., Poloni, E. S., Agúndez, J. A. G., Teixeira, R. L., Boone, E. C., Santos, A. R., Whirl‐Carrillo, M., Sangkuhl, K., Klein, T. E., Habil, M. R., Fakis, G., Minchin, R. F., Hein, D. W., Boukouvala, S., & Gaedigk, A. (2025). PharmVar GeneFocus : NAT2 — Genetic Variation and Updated Nomenclature. Clinical Pharmacology & Therapeutics, 119(4), 859–871. https://doi.org/10.1002/cpt.70168

How many times has this paper been cited?

12 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

Georgia Papanikolaou, Estella S. Poloni, José A. G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin and 3 more.

What is the DOI of this paper?

10.1002/cpt.70168, permanently at https://doi.org/10.1002/cpt.70168. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.